Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
High blood pressure, or hypertension, affects more than 1.5 billion people worldwide and is a major cause of heart disease ...
Aldosterone might have a role in the progression of renal disease; therefore, van den Meiracker et al. investigated whether adding the aldosterone receptor antagonist spironolactone to renin ...
Aldosterone antagonists (spironolactone, eplerenone) also known as “potassium sparing diuretics” block the action of aldosterone inhibiting the reuptake of sodium and water. Normally, when ...
Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has announced the completion of enrollment for its Explore-CKD Phase 2 trial. The ...